GMED vs. OR
GMED (Globus Medical, Inc.) and OR (Osisko Gold Royalties Ltd) are both stocks. GMED operates in Medical Devices (Healthcare), while OR operates in Gold (Basic Materials). Over the past 10 years, GMED returned 12.07%/yr vs 9.90%/yr for OR. At a 0.10 correlation, their price movements are largely independent.
Performance
GMED vs. OR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GMED achieves a -10.54% return, which is significantly higher than OR's -16.97% return. Over the past 10 years, GMED has outperformed OR with an annualized return of 12.07%, while OR has yielded a comparatively lower 9.90% annualized return.
GMED
- 1D
- 1.92%
- 1M
- -2.99%
- 6M
- -17.32%
- YTD
- -10.54%
- 1Y
- 36.75%
- 3Y*
- 8.91%
- 5Y*
- -0.63%
- 10Y*
- 12.07%
OR
- 1D
- -1.58%
- 1M
- -10.39%
- 6M
- -23.87%
- YTD
- -16.97%
- 1Y
- 5.75%
- 3Y*
- 28.20%
- 5Y*
- 18.38%
- 10Y*
- 9.90%
GMED vs. OR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GMED Globus Medical, Inc. | -10.54% | 5.56% | 55.21% | -28.25% | 2.87% | 10.70% | 10.77% | 36.04% | 5.30% | 65.66% |
OR Osisko Gold Royalties Ltd | -16.97% | 96.95% | 28.14% | 19.96% | 0.02% | -2.01% | 32.58% | 12.20% | -22.72% | 20.74% |
Correlation
The correlation between GMED and OR is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Jan 4, 2016 | 0.10 |
Fundamentals
GMED:
$10.53B
OR:
$5.49B
GMED:
$4.28
OR:
$1.34
GMED:
18.23
OR:
21.81
GMED:
0.19
OR:
0.12
GMED:
3.45
OR:
17.03
GMED:
2.28
OR:
3.74
GMED:
$3.10B
OR:
$325.18M
GMED:
$1.58B
OR:
$275.03M
GMED:
$803.34M
OR:
$330.83M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GMED vs. OR — Risk / Return Rank
GMED
OR
GMED vs. OR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and Osisko Gold Royalties Ltd (OR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GMED | OR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.49 | ||
| Sortino ratioReturn per unit of downside risk | +1.17 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.08 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 1.60 | 0.26 | +1.34 |
| Martin ratioReturn relative to average drawdown | 3.87 | 0.60 | +3.27 |
Loading charts...
Drawdowns
GMED vs. OR - Drawdown Comparison
The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum OR drawdown of -61.90%. Use the drawdown chart below to compare losses from any high point for GMED and OR.
Loading charts...
Drawdown Indicators
| GMED | OR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -47.91% | -61.90% | +13.99% |
Max Drawdown (1Y)Largest decline over 1 year | -22.10% | -38.54% | +16.44% |
Max Drawdown (3Y)Largest decline over 3 years | -44.40% | -38.54% | -5.86% |
Max Drawdown (5Y)Largest decline over 5 years | -47.91% | -38.54% | -9.37% |
Max Drawdown (10Y)Largest decline over 10 years | -47.91% | -61.90% | +13.99% |
Current DrawdownCurrent decline from peak | -19.32% | -38.43% | +19.11% |
Average DrawdownAverage peak-to-trough decline | -15.33% | -18.16% | +2.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.13% | 16.70% | -7.57% |
Volatility
GMED vs. OR - Volatility Comparison
Globus Medical, Inc. (GMED) and Osisko Gold Royalties Ltd (OR) have volatilities of 13.69% and 13.74%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GMED | OR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.69% | 13.74% | -0.05% |
Volatility (6M)Calculated over the trailing 6-month period | 25.33% | 38.47% | -13.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.46% | 45.74% | +3.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.27% | 36.04% | +2.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.68% | 38.60% | -2.92% |
Dividends
GMED vs. OR - Dividend Comparison
GMED has not paid dividends to shareholders, while OR's dividend yield for the trailing twelve months is around 0.79%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
GMED Globus Medical, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
OR Osisko Gold Royalties Ltd | 0.79% | 0.59% | 1.02% | 1.34% | 1.38% | 1.37% | 1.18% | 1.56% | 1.72% | 1.56% | 1.65% |
Financials
GMED vs. OR - Financials Comparison
This section allows you to compare key financial metrics between Globus Medical, Inc. and Osisko Gold Royalties Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
GMED vs. OR - Profitability Comparison
GMED - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a gross profit of 0.00 and revenue of 759.85M. Therefore, the gross margin over that period was 0.0%.
OR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Osisko Gold Royalties Ltd reported a gross profit of 87.28M and revenue of 101.41M. Therefore, the gross margin over that period was 86.1%.
GMED - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported an operating income of 150.39M and revenue of 759.85M, resulting in an operating margin of 19.8%.
OR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Osisko Gold Royalties Ltd reported an operating income of 79.13M and revenue of 101.41M, resulting in an operating margin of 78.0%.
GMED - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Globus Medical, Inc. reported a net income of 124.30M and revenue of 759.85M, resulting in a net margin of 16.4%.
OR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Osisko Gold Royalties Ltd reported a net income of 72.56M and revenue of 101.41M, resulting in a net margin of 71.6%.
Frequently Asked Questions
GMED and OR have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
OR has higher volatility (13.74%) compared to GMED (13.69%). In terms of maximum drawdown, GMED dropped -47.91% vs OR's -61.90%.
GMED currently has the higher Sharpe Ratio (0.71 vs 0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GMED and OR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer